Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

4.29DKK
13 Nov 2018
Change (% chg)

-- (--)
Prev Close
kr.4.29
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
99,888
52-wk High
kr.5.20
52-wk Low
kr.2.80

Chart for

About

Neurosearch A/S (NEUR) is Denmark-based biopharmaceutical company. It specializes in the research, development and sale of drug candidates. The Company’s portfolio comprises three products: Tesofensine, a drug used in obesity, which works as a monoamine reuptake inhibitor (MRI); Seridopidine, which is applied in central nervous... (more)
No analyst recommendations are available for .

Overall

Beta: 0.12
Market Cap(Mil.): kr.84.22
Shares Outstanding(Mil.): 24.55
Dividend: --
Yield (%): --

Financials

  NEUR.CO Industry Sector
P/E (TTM): 4.05 85.49 33.64
EPS (TTM): 0.85 -- --
ROI: 29.57 -0.29 14.22
ROE: 29.57 0.40 15.99

BRIEF-RegNeurosearch And Teva Pharmaceutical International Enter Into Agreement On Outstanding Obligations

* REG-NEUROSEARCH AND TEVA PHARMACEUTICAL INTERNATIONAL ENTER INTO AGREEMENT ON OUTSTANDING OBLIGATIONS

May 16 2018

Earnings vs. Estimates

No consensus analysis data available.